The present invention concerns a recently discovered macrophage specific receptor, STIgMA, and its use in the treatment of complement-associated disorders.

 
Web www.patentalert.com

< Methods of making chemokine alpha 3 antibodies

> Methods of protein production in yeast
~ 00458